Alport syndrome

  • Jan 30, 2019 finheadlines.com
    Comparison of Akebia Therapeutics Inc. (AKBA) and Regulus Therapeutics Inc. (NASDAQ:RGLS) – The FinHeadLines
    Read More
  • Jan 30, 2019 endigest.com
    Reviewing Cyclacel Pharmaceuticals Inc. (CYCC)’s and Regulus Therapeutics Inc. (NASDAQ:RGLS)’s results – EN Digest
    Read More
  • Jan 30, 2019 hinewulm.com
    Comparison of Regulus Therapeutics Inc. (RGLS) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) – The Hi New Ulm
    Read More
  • Head-To-Head Survey: Akcea Therapeutics (NASDAQ:AKCA) and Reata Pharmaceuticals (RETA) – Fairfield Current
    Read More
  • Jan 22, 2019 www.thejc.com
    Wife gives husband her kidney in life-saving double operation – Jewish Chronicle
    Read More
  • Jan 21, 2019 alportsyndromenews.com
    Co-occurrence of aHUS, TMA, and Alport Syndrome Suggest Shared Mechanism, Case Report Says – Alport Syndrome News
    Read More
  • Regulus Therapeutics Inc (RGLS) Director Stelios Papadopoulos Acquires 50000 Shares – Fairfield Current
    Read More
  • Jan 14, 2019 alportsyndromenews.com
    In XLAS, COL4A5 Mutations Determine Progression of Hearing Loss, Study Finds – Alport Syndrome News
    Read More
  • Jan 10, 2019 www.nasdaq.com
    Top 5 Losers In Healthcare Sector (PAVM, ATOS, TBIO…) – Nasdaq
    Read More

Connect. Empower. Inspire.